880 - 580 HORNBY STREET, VANCOUVER, A1
Material disclosure
Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
MindWalk to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Amended Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Notice of Exempt Offering of Securities
No filings found
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Correspondence
Submission Upload
Supplemental Filing
Free Writing Prospectus